Quick answer: The ASRS-v1.1 is a WHO-developed 18-item adult ADHD screener (0–72 total). Part A (items 1–6) is the 1-minute quick screen — ≥4 shaded answers = further evaluation warranted. A positive screen identifies candidates for DSM-5 ADHD diagnosis, which requires onset before age 12, symptoms in ≥2 settings, and functional impairment.
Why ASRS-v1.1 Is the Standard Adult ADHD Screener
The ASRS-v1.1 was developed by the World Health Organization with Harvard and New York Universities researchers and validated in the WHO World Mental Health surveys — it is the only adult ADHD screener with that pedigree, which is why guidelines anchor to it. Adult ADHD is missed for decades because adults compensate: high-functioning patients build external scaffolding (lists, alarms, deadlines-as-motivation) that masks the underlying symptoms until a crisis — job loss, divorce, a child's diagnosis — surfaces them. The screener's job is to convert vague "I've always struggled" histories into countable, frequency-rated symptoms that justify the structured diagnostic interview.
The pathway: ASRS screen → clinical interview for DSM-5-TR criteria → rule-outs → diagnosis → treatment plan. The screener is step one; everything after it is clinical work.
The 18 Items — Response Scale
Each item asks "How often" the patient experiences the symptom, rated:
| Response | Points | Shading (Part A) |
|---|---|---|
| Never | 0 | — |
| Rarely | 1 | — |
| Sometimes | 2 | — |
| Often | 3 | Darker shade |
| Very often | 4 | Darkest shade |
Part A vs. Part B — The Two-Stage Screen
| Part | Items | Purpose | Threshold |
|---|---|---|---|
| Part A | 1–6 | 1-minute quick screen | ≥4 of 6 items answered "Sometimes," "Often," or "Very often" (shaded boxes) = positive |
| Part B | 7–18 | Full symptom detail | Adds frequency data for the clinical interview |
Part A is the gate: if fewer than 4 items are shaded, ADHD is unlikely and Part B adds little. If ≥4 are shaded, Part B informs the interview.
The 18 Items at a Glance
| # | Part | Item (abbreviated) |
|---|---|---|
| 1 | A | Trouble wrapping up final details of projects |
| 2 | A | Difficulty getting things in order for organized tasks |
| 3 | A | Problems remembering appointments or obligations |
| 4 | A | Avoiding/delaying tasks requiring sustained thought |
| 5 | A | Fidgeting/squirming when sitting for long periods |
| 6 | A | Feeling overly active, driven by a motor |
| 7 | B | Careless mistakes on boring/difficult projects |
| 8 | B | Difficulty keeping attention on boring/repetitive tasks |
| 9 | B | Difficulty concentrating when spoken to directly |
| 10 | B | Misplacing or having difficulty finding things |
| 11 | B | Background noise/activity a problem when concentrating |
| 12 | B | Drifting off in meetings or conversations |
| 13 | B | Feeling restless or fidgety |
| 14 | B | Difficulty unwinding/relaxing in free time |
| 15 | B | Talking too much in social situations |
| 16 | B | Finishing people's sentences before they can finish |
| 17 | B | Difficulty waiting your turn |
| 18 | B | Interrupting others when busy |
Scoring — What the Numbers Mean
| Score | Interpretation |
|---|---|
| Part A: 0–3 shaded | ADHD unlikely — no further evaluation needed |
| Part A: ≥4 shaded | Positive screen — schedule clinical interview for DSM-5-TR criteria |
| Part B total | Frequency detail for interview — no standalone cutoff |
Screen ≠ diagnosis. ASRS-v1.1 identifies candidates; diagnosis requires DSM-5-TR criteria: ≥5 symptoms per domain (age 17+), onset before age 12, ≥2 settings, functional impairment, and exclusion of other causes (anxiety, depression, sleep deprivation, substance use, thyroid).
ASRS-v1.1 vs. DSM-5 ADHD Criteria — The Gap
| ASRS captures | DSM-5 requires beyond ASRS |
|---|---|
| Current symptom frequency (past 6 months) | Onset before age 12 — requires developmental history |
| Adult symptom experience | ≥2 settings — requires collateral (spouse, employer, school records) |
| Self-reported impairment proxy | Formal functional impairment documentation |
| Symptom presence | Exclusion criteria — rule out anxiety, mood, substance, medical |
ASRS in Different Populations
| Population | Guidance |
|---|---|
| Adults 18+ | ASRS-v1.1 is the validated instrument |
| Adolescents 13–17 | ASRS has adolescent versions; clinical interview still required |
| Children under 12 | Use Vanderbilt or Conners scales — ASRS is adult-focused |
| Non-English speakers | Validated translations available; use official versions for score comparability |
Scoring Examples
| Part A pattern | Score | Interpretation |
|---|---|---|
| 2 shaded items | 2/6 | Negative — ADHD unlikely; consider anxiety/depression screens |
| 4 shaded items | 4/6 | Positive — schedule DSM-5-TR interview |
| 6 shaded items | 6/6 | Strongly positive — prioritize evaluation; high symptom burden |
| Part B total | Interpretation |
|---|---|
| 0–12 | Low symptom frequency |
| 13–24 | Moderate frequency — informs interview domains |
| 25–48 | High frequency — corroborate with collateral sources |
The Differential — Rule Out Before Stimulants
Adult ADHD shares symptom space with several conditions that stimulants can worsen. The rule-out sequence before prescribing:
| Rule-out | Why | Tool |
|---|---|---|
| Bipolar disorder | Stimulants can precipitate mania; hyperactivity mimics hypomania | MDQ — positive screen → establish bipolar history first |
| Major depression | Anhedonia and concentration failure mimic inattention | PHQ-9 |
| Anxiety disorders | Restlessness and poor concentration from worry | GAD-7 |
| Substance use | Stimulant misuse and withdrawal mimic ADHD symptoms | Clinical history + urine drug screen |
| Sleep deprivation / OSA | Fatigue-driven inattention | Sleep history; refer for sleep study if indicated |
| Thyroid disease | Fatigue, restlessness, concentration problems | TSH |
The MDQ bipolar rule-out is the critical one — a positive MDQ before stimulant initiation changes the entire treatment plan. Document the rule-out explicitly; it is the first thing a payer or malpractice reviewer looks for in an adult stimulant chart.
Comorbidity Patterns
ADHD co-occurs with depression (~40%), anxiety (~30–50%), substance use disorders (elevated, especially nicotine and stimulants), and learning disorders. Code each independently when criteria are met — comorbid documentation supports treatment complexity.
Tracking Treatment Response
The ASRS is a screen, not a severity tracker — for ongoing measurement use symptom-specific follow-up (e.g., ADHD RS-IV with adult prompts) or document functional outcomes (missed deadlines, appointment adherence). Re-administer ASRS Part A at treatment milestones to confirm sustained symptom reduction.
How Neuraline Streamlines Adult ADHD Care
| Workflow | Neuraline capability |
|---|---|
| Screening | AI Screening module — ASRS-v1.1 pre-seeded with auto-scoring; MDQ, PHQ-9, GAD-7 co-administered for the rule-out stack |
| Diagnosis | Encounter templates with DSM-5-TR ADHD criteria checklists (onset, settings, impairment) |
| Prescribing | EPCS — controlled-substance e-prescribing with identity-proofed two-factor signing for stimulants |
| Compliance | PDMP integration — prescription-drug-monitoring checks before each controlled fill |
| Documentation | 3-click AI Charting — SOAP/DAP notes draft with scores, criteria, and plan embedded |
Related Resources
- ASRS-v1.1 printable PDF — 18-item worksheet
- DSM-5 Criteria: ADHD, PTSD & OCD Screening — full ADHD criteria A–E
- DSM-5-TR Criteria Quick Reference
- Neuraline screening feature · Psychiatry · Mental health · Pediatrics
Clinical Documentation Snippet
ASRS-v1.1 administered: Part A score 5/6 shaded (positive screen ≥4). Part B total 31/72 — frequent symptoms across inattention and hyperactivity domains. Patient reports lifelong difficulty with organization, time management, and follow-through; spouse corroborates. Onset before age 12 per patient and family history. PHQ-9 8 (mild depression — ruled out as primary cause). Clinical interview scheduled to establish DSM-5-TR ADHD criteria. CPT 96127 billed.
Frequently Asked Questions
What is a positive ASRS score?
≥4 of the 6 Part A items answered "Sometimes," "Often," or "Very often" (the shaded boxes) is the positive-screen threshold. It flags the patient for a DSM-5-TR clinical interview — it is not a diagnosis.
Is ASRS-v1.1 the same as the online adult ADHD tests?
The ASRS-v1.1 is the validated WHO instrument that most reputable online ADHD tests are built from. Many websites modify it or skip scoring rules — for clinical use, administer the official 18-item version with the standard Part A/Part B structure and document the score.
Can the ASRS diagnose ADHD?
No. It screens. Diagnosis requires the DSM-5-TR criteria interview: ≥5 symptoms per domain (age 17+), onset before age 12, symptoms in ≥2 settings, functional impairment, and explicit rule-outs (bipolar via MDQ, depression via PHQ-9, substance use, sleep, thyroid).
How is the ASRS scored — what does Part A mean?
Part A is items 1–6, the six questions most predictive of ADHD in validation studies; ≥4 shaded answers = positive screen. Part B is items 7–18, adding symptom-frequency detail for the interview. The full 18-item total (0–72) has no standalone diagnostic cutoff — Part A is the gate.
This guide summarizes ASRS-v1.1 scoring for clinical reference. Screening scores require clinical interpretation — they are not diagnoses.
Screen for adult ADHD systematically with Neuraline's AI Screening module — ASRS-v1.1 alongside PHQ-9, GAD-7, Y-BOCS, BDI, HAM-D, and MMSE. Explore screening or book a demo.
About Neuraline
Neuraline (neura-line.com) is an AI-powered Electronic Health Record (EHR), practice management, and medical billing platform for independent healthcare practices.
